Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Abstracts from Current Literature

Abstracts from Current Literature and Biochemistry; Bacteriology, Pathology Further Observations of an Inhibitor in of the Human Serums Hyaluronidase Produced by a Strain of Hemolytic Streptococcus. George Infect. Dis. 84:240 1949. J. Friou, (May-June) J. an Further studies were done on inhibitor in human serums of the hyaluronidase derived from a strain of of 4. The titer Streptococcus hemolyticus group A, type of this inhibitor in the serum increased convalescence in most of 50 cases during of scarlet fever. The maximum titer of the inhibitor was reached more than cases. fourteen after the onset of the infection in most of the The inhibitor days was for the of the A and the highly specific hyaluronidase group streptococcus, in titer the in titer of approximately paralleled antistreptokinase changes changes O. An inhibitor with similar effect the and antistreptolysin a specific on hyalur¬ to concentrated in onidase A was shown be produced by group streptococci pooled 56 C. human The inhibitor in whole serum was stable at purified gamma globulin. (132.8 F.) for The distribution of titers serums relatively long periods. among from infants and children was such as to that transfer of the inhibitor suggest from the maternal to the fetal circulation and that http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American journal of diseases of children American Medical Association

Abstracts from Current Literature

American journal of diseases of children , Volume 79 (5) – May 1, 1950
Download PDF
50 pages

Loading next page...
 
/lp/american-medical-association/abstracts-from-current-literature-8t8T89p0WN

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1950 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0096-8994
eISSN
1538-3628
DOI
10.1001/archpedi.1950.04040010885010
Publisher site
See Article on Publisher Site

Abstract

and Biochemistry; Bacteriology, Pathology Further Observations of an Inhibitor in of the Human Serums Hyaluronidase Produced by a Strain of Hemolytic Streptococcus. George Infect. Dis. 84:240 1949. J. Friou, (May-June) J. an Further studies were done on inhibitor in human serums of the hyaluronidase derived from a strain of of 4. The titer Streptococcus hemolyticus group A, type of this inhibitor in the serum increased convalescence in most of 50 cases during of scarlet fever. The maximum titer of the inhibitor was reached more than cases. fourteen after the onset of the infection in most of the The inhibitor days was for the of the A and the highly specific hyaluronidase group streptococcus, in titer the in titer of approximately paralleled antistreptokinase changes changes O. An inhibitor with similar effect the and antistreptolysin a specific on hyalur¬ to concentrated in onidase A was shown be produced by group streptococci pooled 56 C. human The inhibitor in whole serum was stable at purified gamma globulin. (132.8 F.) for The distribution of titers serums relatively long periods. among from infants and children was such as to that transfer of the inhibitor suggest from the maternal to the fetal circulation and that

Journal

American journal of diseases of children – American Medical Association

Published: May 1, 1950

There are no references for this article.